JP2024532882A5 - - Google Patents
Info
- Publication number
- JP2024532882A5 JP2024532882A5 JP2024512156A JP2024512156A JP2024532882A5 JP 2024532882 A5 JP2024532882 A5 JP 2024532882A5 JP 2024512156 A JP2024512156 A JP 2024512156A JP 2024512156 A JP2024512156 A JP 2024512156A JP 2024532882 A5 JP2024532882 A5 JP 2024532882A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- fusion protein
- seq
- protein according
- variant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110977378.7 | 2021-08-24 | ||
| CN202110977378 | 2021-08-24 | ||
| PCT/CN2022/114096 WO2023025120A1 (en) | 2021-08-24 | 2022-08-23 | Gdf15 fusion proteins and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024532882A JP2024532882A (ja) | 2024-09-10 |
| JP2024532882A5 true JP2024532882A5 (cg-RX-API-DMAC7.html) | 2025-08-07 |
Family
ID=85321545
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024512156A Pending JP2024532882A (ja) | 2021-08-24 | 2022-08-23 | Gdf15融合タンパク質及びその使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US20240350588A1 (cg-RX-API-DMAC7.html) |
| EP (3) | EP4393941A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024532882A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240049337A (cg-RX-API-DMAC7.html) |
| CN (3) | CN115925982A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022333099A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3226178A1 (cg-RX-API-DMAC7.html) |
| WO (3) | WO2023025120A1 (cg-RX-API-DMAC7.html) |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101374454B1 (ko) * | 2005-03-31 | 2014-03-17 | 추가이 세이야쿠 가부시키가이샤 | 회합제어에 의한 폴리펩티드 제조방법 |
| JP2013537416A (ja) * | 2010-08-13 | 2013-10-03 | メディミューン リミテッド | 変異型Fc領域を含むモノマーポリペプチド及び使用方法 |
| KR20140125803A (ko) * | 2012-01-26 | 2014-10-29 | 암젠 인크 | 성장 분화 인자 15(gdf-15) 폴리펩타이드들 |
| CN105102618B (zh) * | 2012-12-27 | 2018-04-17 | 中外制药株式会社 | 异源二聚化多肽 |
| EP3027647A4 (en) * | 2013-07-31 | 2017-01-04 | Amgen Inc. | Stabilization of fc-containing polypeptides |
| LT3027642T (lt) * | 2013-07-31 | 2020-10-12 | Amgen Inc. | Augimo ir diferenciacijos faktoriaus 15(gdf-15) konstruktai |
| SG10201913507SA (en) * | 2014-05-02 | 2020-02-27 | Momenta Pharmaceuticals Inc | Compositions and methods related to engineered fc constructs |
| US10336812B2 (en) * | 2016-05-10 | 2019-07-02 | Janssen Biotech, Inc. | GDF15 fusion proteins and uses thereof |
| WO2018166461A1 (en) * | 2017-03-14 | 2018-09-20 | Sunshine Lake Pharma Co., Ltd. | Dual-target fusion proteins comprising the fc portion of an immunoglobulin |
| TWI724392B (zh) * | 2018-04-06 | 2021-04-11 | 美商美國禮來大藥廠 | 生長分化因子15促效劑化合物及其使用方法 |
| US12054527B2 (en) * | 2018-04-09 | 2024-08-06 | Amgen Inc. | Growth differentiation factor 15 fusion proteins |
| CN113286812B (zh) * | 2018-09-27 | 2025-05-30 | 西里欧发展公司 | 掩蔽型细胞因子多肽 |
| KR20210080460A (ko) * | 2018-10-23 | 2021-06-30 | 드래곤플라이 쎄라퓨틱스, 인크. | 이종이량체성 Fc-융합된 단백질 |
| BR112021021271A2 (pt) * | 2019-04-23 | 2021-12-21 | Lg Chemical Ltd | Polipeptídeo de fusão compreendendo região fc de imunoglobulina e gdf15 |
| BR112022007128A2 (pt) * | 2019-10-15 | 2022-07-05 | Dragonfly Therapeutics Inc | Ligação de proteínas nkg2d, cd16 e flt3 |
| CA3161302A1 (en) * | 2019-11-26 | 2021-06-03 | Yuhan Corporation | Long-acting gdf15 fusion protein and pharmaceutical composition comprising same |
| CA3171363A1 (en) * | 2019-12-20 | 2021-06-24 | Kisoji Biotechnology Inc. | Polypeptides, protein complexes and method for making same |
| EP4458863A1 (en) * | 2021-12-31 | 2024-11-06 | Sunshine Lake Pharma Co., Ltd. | Fusion protein of glp-1 and gdf15 and use thereof |
-
2022
- 2022-08-23 US US18/682,002 patent/US20240350588A1/en active Pending
- 2022-08-23 WO PCT/CN2022/114096 patent/WO2023025120A1/en not_active Ceased
- 2022-08-23 CN CN202211012820.3A patent/CN115925982A/zh active Pending
- 2022-08-23 US US18/685,702 patent/US20240391971A1/en active Pending
- 2022-08-23 KR KR1020247009488A patent/KR20240049337A/ko active Pending
- 2022-08-23 CN CN202211013315.0A patent/CN115925984A/zh active Pending
- 2022-08-23 US US18/294,397 patent/US20240343770A1/en active Pending
- 2022-08-23 CN CN202211012940.3A patent/CN115925983A/zh active Pending
- 2022-08-23 AU AU2022333099A patent/AU2022333099A1/en active Pending
- 2022-08-23 EP EP22860469.0A patent/EP4393941A4/en active Pending
- 2022-08-23 WO PCT/CN2022/114130 patent/WO2023025123A1/zh not_active Ceased
- 2022-08-23 CA CA3226178A patent/CA3226178A1/en active Pending
- 2022-08-23 EP EP22860466.6A patent/EP4392461A4/en active Pending
- 2022-08-23 WO PCT/CN2022/114143 patent/WO2023025129A1/zh not_active Ceased
- 2022-08-23 JP JP2024512156A patent/JP2024532882A/ja active Pending
- 2022-08-23 EP EP22860475.7A patent/EP4393940A4/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11229694B2 (en) | Vaccine against RSV | |
| CN101010338B (zh) | 成纤维细胞生长因子21的突变蛋白 | |
| US7622445B2 (en) | Muteins of fibroblast growth factor 21 | |
| CA3031856C (en) | Mg53 mutants, methods of making the same, and uses thereof | |
| UA81897C2 (uk) | Гетерологічний пептидильований глюкагон-1-подібний білок та його застосування для для виготовлення лікарського засобу для лікування пацієнтів, що страждають на ожиріння та/або інсулінонезалежний діабет | |
| CN103998462A (zh) | Wnt组合物及此类组合物的治疗应用 | |
| JP2011528222A5 (cg-RX-API-DMAC7.html) | ||
| CA3025441A1 (en) | Stabilized pre-fusion rsv f proteins | |
| US9474792B2 (en) | Method of treating metabolic disorders using PLA2G12A polypeptides and PLA2G12A mutant polypeptides | |
| US11746134B2 (en) | Human FGF21 mutant with improved effectiveness and stability and pharmaceutical composition thereof | |
| BRPI0615538A2 (pt) | proteìna de fusão, ácido nucléico isolado, vetor, célula hospedeira, método de produção de um polipeptìdio, composição farmacêutica, composição alimentar, método para a redução do peso corpóreo, método para o tratamento de diabetes, método para aumentar a vida média de um peptìdio ou uma proteìna terapêutica recombinante em um indivìduo, método para aumentar a eficácia de um peptìdio ou proteìna terapêutica, método para o tratamento de diabetes ou redução do peso corpóreo | |
| JP2020511425A5 (cg-RX-API-DMAC7.html) | ||
| JP2023516422A (ja) | ウリナスタチンポリペプチド | |
| CN1869072A (zh) | 与胶原特异结合的神经生长因子及其编码基因与应用 | |
| KR20250148592A (ko) | R-스폰딘 단백질의 재조합 변이체 및 그의 용도 | |
| CN1129944A (zh) | 新型蛋白质及其制备方法 | |
| HK40051815A (en) | Vaccine against rsv comprising modified f polypeptide | |
| CN119285745A (zh) | TGF-β受体激动剂多肽及其用途 | |
| CN117980323A (zh) | R-spondin蛋白的重组变体及其用途 | |
| CN115925982A (zh) | Gdf15融合蛋白及其用途 | |
| HK1250939B (en) | Vaccine against rsv |